Comparative analysis of Indian pharmaceutical companies during Covid

Comparative analysis of Indian pharmaceutical companies during Covid
Author(s):
B Ashok, Navaneeth J, Rahul C
Keywords:

Abstract
The coronavirus pandemic's effects on India have primarily disrupted economic activities and resulted in fatalities. Almost every industry has suffered as domestic demand and exports have dramatically decreased, with some notable outliers where strong growth has been seen. Analysis of the effects and potential remedies for several important industries is attempted. Since the Covid-19 pandemic began, the pharmaceutical business has grown, particularly in India, the world's top producer of generic medications. In the beginning of 2020, it had a market of $55 billion and was booming in India, supplying hydroxychloroquine to countries all over the world, including the US, UK, Canada, and the Middle East.
Article Details
Unique Paper ID: 158201 Publication Volume & Issue: Volume 9, Issue 9 Page(s): 163 - 169
Article Preview & Download

Share This Article

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024

Last Date: 15th March 2024

IJIRT.org enables door in research by providing high quality research articles in open access market.

Send us any query related to your research on editor@ijirt.org